Bristol-Myers Profit, 2011 Forecast Miss Estimates on Taxes

[guest]

Bristol-Myers Squibb Co., whose top- selling blood thinner Plavix faces generic competition next year, said fourth-quarter profit decreased 41 percent, missing analyst estimates after one-time tax charges from restructuring.


More...

Toggle signature
||||| Mentor Group Access Now! |||||